Herein, we selected two representative Notch receptors (NOTCH1 and NOTCH2), NICD (NOTCH1 intracellular domain, also known as activated NOTCH1), and HES1 (downstream effector) as targets and conducted an immunohistochemical study on tumor samples. The gene discussed is HES1; the disease is neoplasm.